0.8(top 50%)
impact factor
178(top 50%)
papers
6.0K(top 20%)
citations
26(top 20%)
h-index
2.9(top 20%)
impact factor
6.3K
all documents
6.4K
doc citations
38(top 20%)
g-index

Top Articles

#TitleJournalYearCitations
1Acute kidney injury and chronic kidney disease: From the laboratory to the clinicNephrologie Et Therapeutique201696
2Orthostatic hypotension: A reviewNephrologie Et Therapeutique201772
3Uremic toxicity and sclerostin in chronic kidney disease patientsNephrologie Et Therapeutique201471
4New insights on inflammation in chronic kidney disease–genetic and non-genetic factorsNephrologie Et Therapeutique200658
5The contribution of adult stem cells to renal repairNephrologie Et Therapeutique200756
6The past, presence and future of ADMA in nephrologyNephrologie Et Therapeutique200738
7Ten-years trends in renal replacement therapy for end-stage renal disease in mainland France: Lessons from the French Renal Epidemiology and Information Network (REIN) registryNephrologie Et Therapeutique201737
8The essential of 2012 results from the French Renal Epidemiology and Information Network (REIN) ESRD registryNephrologie Et Therapeutique201536
9Prognosis and treatment of diabetic nephropathy: Recent advances and perspectivesNephrologie Et Therapeutique201835
10Preemptive kidney transplantation: Has it come of age?Nephrologie Et Therapeutique201233
11Clinical spectrum of primary hyperoxaluria type 1: Experience of a tertiary centerNephrologie Et Therapeutique201733
12Treatment of IgA nephropathy: Recent advances and prospectsNephrologie Et Therapeutique201833
13Mitochondrial cytopathies and the kidneyNephrologie Et Therapeutique201731
14Recent advances in the physiopathology of IgA nephropathyNephrologie Et Therapeutique201830
15Encapsulating peritoneal sclerosis – an overviewNephrologie Et Therapeutique201127
16Intracellular organelles in health and kidney diseaseNephrologie Et Therapeutique201925
17Socio-economic impact in CKDNephrologie Et Therapeutique201324
18Complement inhibition in ANCA vasculitisNephrologie Et Therapeutique201921
19Serum and urinary biomarkers in acute kidney transplant rejectionNephrologie Et Therapeutique201219
20New aspects on the pathogenesis of renal disorders related to monoclonal gammopathiesNephrologie Et Therapeutique201519
21Assessing the prevalence of protein-energy wasting in haemodialysis patients: A cross-sectional monocentric studyNephrologie Et Therapeutique201718
22Thrombotic microangiopathies and antineoplastic agentsNephrologie Et Therapeutique201718
23Lessons learnt from the 4D trialNephrologie Et Therapeutique200617
24Renin–angiotensin system blockade: FinerenoneNephrologie Et Therapeutique201717
25Oxygen sensors as therapeutic targets in kidney diseaseNephrologie Et Therapeutique201715
26The measured glomerular filtration rate (mGFR) before and 6 months after bariatric surgery: A pilot studyNephrologie Et Therapeutique201714
27Genomic analysis in nephrology – towards systems biology and systematic medicine?Nephrologie Et Therapeutique200813
28A case of successfully treated relapsing peritoneal dialysis-associated peritonitis caused by Gordonia bronchialis in a farmerNephrologie Et Therapeutique201813
29Human monocyte heterogeneity–a nephrological perspectiveNephrologie Et Therapeutique201012
30Maremar, prevalence of chronic kidney disease, how to avoid over-diagnosis and under-diagnosisNephrologie Et Therapeutique201612
31Association of overhydration and cardiac dysfunction in patients have chronic kidney disease but not yet dialysisNephrologie Et Therapeutique201612
32Molecular pathways of chronic kidney disease progressionNephrologie Et Therapeutique201611
33Prevalence of herbal medicine use among patients with kidney disease: A cross-sectional study from MoroccoNephrologie Et Therapeutique202011
34Genetics of kidney stone disease—Polygenic meets monogenicNephrologie Et Therapeutique202110
35Screening for Fabry disease in male patients with end-stage renal disease in western FranceNephrologie Et Therapeutique20219
36Is peritoneal dialysis a therapeutic option for polycystic kidney disease? 15 years’ experience in a single centerNephrologie Et Therapeutique20168
37Impact of Covid-19 on kidney transplant and waiting list patients: Lessons from the first wave of the pandemicNephrologie Et Therapeutique20218
38Fabry disease: clinical spectrum and evidence-based enzyme replacement therapyNephrologie Et Therapeutique20068
39Which data in the French registry for advanced chronic kidney disease for public health and patient care?Nephrologie Et Therapeutique20228
40Extracorporeal ultrafiltration for heart failure: Focus on organ cross talk and clinical trialsNephrologie Et Therapeutique20147
41Recent advances in the treatment of renal diseases with nebivolol: A literature reviewNephrologie Et Therapeutique20167
42Dual renin–angiotensin system blockade for nephroprotectionNephrologie Et Therapeutique20177
43The role of donor-derived cell-free DNA in the detection of renal allograft injuryNephrologie Et Therapeutique20217
44Règles d'utilisation des biosimilairesNephrologie Et Therapeutique20066
45Bilateral nephrectomy for uncontrolled hypertension in hemodialysis patient: A forgotten option?Nephrologie Et Therapeutique20146
46Changes of etiology, incidence and outcomes of severe acute kidney injury during a 12-year period (2001–2012) in large university hospitalNephrologie Et Therapeutique20166
47Renal embolizationNephrologie Et Therapeutique20166
48Acute renal cortical necrosis in pregnancy: Clinical course and changing prognosisNephrologie Et Therapeutique20176
49Plasmacytoma-like post-kidney-transplant lymphoproliferative disorder confined to renal allograft and urinary tract: A case reportNephrologie Et Therapeutique20186
50Reasons for dialysis patients choosing or refusing kidney transplantation as renal replacement therapy: A qualitative studyNephrologie Et Therapeutique20196